{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T23:38:30Z","timestamp":1783726710315,"version":"3.55.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Oncol Rep"],"DOI":"10.1007\/s11912-026-01762-x","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T05:19:53Z","timestamp":1771219193000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Integrative Oncology for Biochemical Recurrence of Epithelial Ovarian Cancer"],"prefix":"10.1007","volume":"28","author":[{"given":"Tara","family":"Berman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emad","family":"Matanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen Ben","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0245-0764","authenticated-orcid":false,"given":"Moshe","family":"Frenkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"issue":"6","key":"1762_CR1","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/cncr.24149","volume":"115","author":"A du Bois","year":"2009","unstructured":"du Bois A, Reuss A, Pujade-Lauraine E, Harter P, Ray-Coquard I, Pfisterer J. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials. Cancer. 2009;115(6):1234\u201344. https:\/\/doi.org\/10.1002\/cncr.24149.","journal-title":"Cancer"},{"key":"1762_CR2","doi-asserted-by":"publisher","unstructured":"Colombo N, Sessa C, du Bois A et al. ESMO\u2013ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease. Int J Gynecol Cancer. 2019;29(4):728\u2013760. https:\/\/doi.org\/10.1136\/ijgc-2019-000308","DOI":"10.1136\/ijgc-2019-000308"},{"issue":"9747","key":"1762_CR3","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/S0140-6736(10)61268-8","volume":"376","author":"GJ Rustin","year":"2010","unstructured":"Rustin GJ, van der Burg ME, Griffin CL, et al. Early versus delayed treatment of relapsed ovarian cancer (MRC OV05\/EORTC 55955): a randomised trial. Lancet. 2010;376(9747):1155\u201363. https:\/\/doi.org\/10.1016\/S0140-6736(10)61268-8.","journal-title":"Lancet"},{"issue":"4","key":"1762_CR4","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1093\/oxfordjournals.annonc.a010640","volume":"7","author":"GJ Rustin","year":"1996","unstructured":"Rustin GJ, Nelstrop AE, McClean P, et al. Defining response of ovarian carcinoma to initial chemotherapy according to CA-125: a North Thames ovary group study. Ann Oncol. 1996;7(4):361\u20138. https:\/\/doi.org\/10.1093\/oxfordjournals.annonc.a010640.","journal-title":"Ann Oncol"},{"issue":"20","key":"1762_CR5","doi-asserted-by":"publisher","first-page":"4054","DOI":"10.1200\/JCO.2001.19.20.4054","volume":"19","author":"GJ Rustin","year":"2001","unstructured":"Rustin GJ, Marples M, Nelstrop AE, Mahmoudi M, Meyer T. Use of CA-125 to define progression of ovarian cancer in patients with persistently elevated levels. J Clin Oncol. 2001;19(20):4054\u201361. https:\/\/doi.org\/10.1200\/JCO.2001.19.20.4054.","journal-title":"J Clin Oncol"},{"issue":"9","key":"1762_CR6","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1054\/bjoc.2000.1126","volume":"82","author":"T Meyer","year":"2000","unstructured":"Meyer T, Rustin GJ. Role of tumour markers in monitoring epithelial ovarian cancer. Br J Cancer. 2000;82(9):1535\u20138. https:\/\/doi.org\/10.1054\/bjoc.2000.1126.","journal-title":"Br J Cancer"},{"issue":"2","key":"1762_CR7","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.ygyno.2006.03.004","volume":"103","author":"TS Barlow","year":"2006","unstructured":"Barlow TS, Przybylski M, Schilder JM, Moore DH, Look KY. CA125 velocity as a predictor of clinical recurrence in ovarian cancer patients. Gynecol Oncol. 2006;103(2):535\u20138. https:\/\/doi.org\/10.1016\/j.ygyno.2006.03.004.","journal-title":"Gynecol Oncol"},{"issue":"5","key":"1762_CR8","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1111\/j.1525-1438.2005.00258.x","volume":"15","author":"A Santillan","year":"2005","unstructured":"Santillan A, Garg R, Zahurak ML, Gardner GJ, Giuntoli RL, Armstrong DK. Risk of recurrence in ovarian cancer patients with rising serum CA-125 levels within the normal range. Int J Gynecol Cancer. 2005;15(5):1070\u20133. https:\/\/doi.org\/10.1111\/j.1525-1438.2005.00258.x.","journal-title":"Int J Gynecol Cancer"},{"issue":"8","key":"1762_CR9","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/nm1447","volume":"12","author":"PH Thaker","year":"2006","unstructured":"Thaker PH, Han LY, Kamat AA, et al. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med. 2006;12(8):939\u201344. https:\/\/doi.org\/10.1038\/nm1447.","journal-title":"Nat Med"},{"issue":"3","key":"1762_CR10","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1007\/s00520-021-06659-y","volume":"30","author":"PA Cohen","year":"2022","unstructured":"Cohen PA, Musiello T, Jeffares S, Bennett K. Mindfulness-based cognitive therapy for fear of cancer recurrence in ovarian cancer survivors: a pilot study. Support Care Cancer. 2022;30(3):2317\u201325. https:\/\/doi.org\/10.1007\/s00520-021-06659-y.","journal-title":"Support Care Cancer"},{"issue":"25","key":"1762_CR11","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1200\/JCO.2018.79.2721","volume":"36","author":"GH Lyman","year":"2018","unstructured":"Lyman GH, Greenlee H, Bohlke K, et al. Integrative therapies during and after breast cancer treatment: ASCO endorsement of the SIO clinical practice guideline. J Clin Oncol. 2018;36(25):2647\u201355. https:\/\/doi.org\/10.1200\/JCO.2018.79.2721.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1762_CR12","first-page":"47","volume":"6","author":"SC Danhauer","year":"2008","unstructured":"Danhauer SC, Tooze JA, Farmer DF, et al. Restorative yoga for women with ovarian or breast cancer: findings from a pilot study. J Soc Integr Oncol. 2008;6(2):47\u201358.","journal-title":"J Soc Integr Oncol"},{"key":"1762_CR13","doi-asserted-by":"publisher","first-page":"153473542210892","DOI":"10.1177\/15347354221089221","volume":"21","author":"G Deng","year":"2022","unstructured":"Deng G, Bao T, Mao JJ, et al. Effects of vigorous versus restorative yoga on objective cognitive function in sedentary breast and ovarian cancer survivors: a randomized controlled trial. Integr Cancer Ther. 2022;21:15347354221089221. https:\/\/doi.org\/10.1177\/15347354221089221.","journal-title":"Integr Cancer Ther"},{"issue":"11","key":"1762_CR14","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1002\/pon.798","volume":"13","author":"DW Kissane","year":"2004","unstructured":"Kissane DW, Grabsch B, Clarke DM, et al. Supportive-expressive group therapy: the transformation of existential ambivalence into creative living while enhancing adherence to anti-cancer therapies. Psychooncology. 2004;13(11):755\u201368. https:\/\/doi.org\/10.1002\/pon.798.","journal-title":"Psychooncology"},{"issue":"3","key":"1762_CR15","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.ygyno.2020.06.485","volume":"158","author":"TL Jones","year":"2020","unstructured":"Jones TL, Sandler CX, Spence RR, Hayes SC. Physical activity and exercise in women with ovarian cancer: a systematic review. Gynecol Oncol. 2020;158(3):803\u201311. https:\/\/doi.org\/10.1016\/j.ygyno.2020.06.485.","journal-title":"Gynecol Oncol"},{"issue":"7","key":"1762_CR16","doi-asserted-by":"publisher","first-page":"4055","DOI":"10.1007\/s00520-020-05961-5","volume":"29","author":"Y Segev","year":"2021","unstructured":"Segev Y, Lavie O, Stein N, et al. Correlation between an integrative oncology treatment program and survival in patients with advanced gynecological cancer. Support Care Cancer. 2021;29(7):4055\u201364. https:\/\/doi.org\/10.1007\/s00520-020-05961-5.","journal-title":"Support Care Cancer"},{"issue":"7","key":"1762_CR17","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1089\/acm.2008.0521","volume":"15","author":"W Lu","year":"2009","unstructured":"Lu W, Matulonis UA, Doherty-Gilman A, et al. Acupuncture for chemotherapy-induced neutropenia in patients with gynecologic malignancies: a pilot randomized, sham-controlled trial. J Altern Complement Med. 2009;15(7):745\u201353. https:\/\/doi.org\/10.1089\/acm.2008.0521.","journal-title":"J Altern Complement Med"},{"issue":"3","key":"1762_CR18","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1089\/acm.2016.0181","volume":"23","author":"TJ Chien","year":"2017","unstructured":"Chien TJ, Liu CY, Fang CJ, Kuo CW. The effect of acupuncture in breast cancer-related hot flashes: a systematic review and meta-analysis. J Altern Complement Med. 2017;23(3):164\u201373. https:\/\/doi.org\/10.1089\/acm.2016.0181.","journal-title":"J Altern Complement Med"},{"issue":"4","key":"1762_CR19","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/NCC.0000000000000180","volume":"38","author":"CH Yeh","year":"2015","unstructured":"Yeh CH, Chien LC, Lin WC, Bovbjerg DH, van Londen G, Tsai SL. Pilot randomized controlled trial of auricular point acupressure to manage symptom clusters of pain, fatigue, and disturbed sleep in breast cancer survivors. Cancer Nurs. 2015;38(4):279\u201388. https:\/\/doi.org\/10.1097\/NCC.0000000000000180.","journal-title":"Cancer Nurs"},{"issue":"6","key":"1762_CR20","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1188\/12.ONF.568-577","volume":"39","author":"G Wyatt","year":"2012","unstructured":"Wyatt G, Sikorskii A, Rahbar MH, Victorson D, You M. Health-related quality-of-life outcomes: a reflexology trial with patients with advanced-stage breast cancer. Oncol Nurs Forum. 2012;39(6):568\u201377. https:\/\/doi.org\/10.1188\/12.ONF.568-577.","journal-title":"Oncol Nurs Forum"},{"issue":"7","key":"1762_CR21","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s10552-016-0760-5","volume":"27","author":"N Shivappa","year":"2016","unstructured":"Shivappa N, H\u00e9bert JR, Rosato V, et al. Dietary inflammatory index and ovarian cancer risk in an Italian case-control study. Cancer Causes Control. 2016;27(7):897\u2013906. https:\/\/doi.org\/10.1007\/s10552-016-0760-5.","journal-title":"Cancer Causes Control"},{"issue":"4","key":"1762_CR22","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s00520-014-2451-1","volume":"23","author":"M Mardas","year":"2015","unstructured":"Mardas M, Jamka M, M\u0105dry R, et al. Dietary habit changes and quality of life in patients undergoing chemotherapy for epithelial ovarian cancer. Support Care Cancer. 2015;23(4):1015\u201323. https:\/\/doi.org\/10.1007\/s00520-014-2451-1.","journal-title":"Support Care Cancer"},{"issue":"1","key":"1762_CR23","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3945\/ajcn.114.105395","volume":"102","author":"PM Webb","year":"2015","unstructured":"Webb PM, de Fazio A, Protani MM, et al. Circulating 25-hydroxyvitamin D and survival in women with ovarian cancer: results from the Australian ovarian cancer study. Am J Clin Nutr. 2015;102(1):109\u201314. https:\/\/doi.org\/10.3945\/ajcn.114.105395.","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"1762_CR24","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1517\/14796694.1.6.771","volume":"1","author":"AH Lee","year":"2005","unstructured":"Lee AH, Fraser ML, Binns CW. Possible role for green tea in ovarian cancer prevention. Future Oncol. 2005;1(6):771\u20137. https:\/\/doi.org\/10.1517\/14796694.1.6.771.","journal-title":"Future Oncol"},{"issue":"8","key":"1762_CR25","first-page":"713","volume":"11","author":"M Zhang","year":"2002","unstructured":"Zhang M, Binns CW, Lee AH. Tea consumption and ovarian cancer risk: a case-control study in China. Cancer Epidemiol Biomarkers Prev. 2002;11(8):713\u20138.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"1762_CR26","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1111\/j.1048-891X.2004.14410.x","volume":"14","author":"WS Ahn","year":"2004","unstructured":"Ahn WS, Kim DJ, Chae GT, et al. Natural killer cell activity and quality of life were improved by consumption of a mushroom extract (Agaricus Blazei Murill) in gynecologic cancer patients. Int J Gynecol Cancer. 2004;14(4):589\u201394. https:\/\/doi.org\/10.1111\/j.1048-891X.2004.14410.x.","journal-title":"Int J Gynecol Cancer"},{"issue":"51","key":"1762_CR27","doi-asserted-by":"publisher","first-page":"89108","DOI":"10.18632\/oncotarget.19059","volume":"8","author":"Y Ma","year":"2017","unstructured":"Ma Y, Yu J, Zhu J, et al. Can polysaccharide-K (PSK) improve therapeutic efficacy in Gastrointestinal cancers? A systematic review and meta-analysis. Oncotarget. 2017;8(51):89108\u201318. https:\/\/doi.org\/10.18632\/oncotarget.19059.","journal-title":"Oncotarget"},{"issue":"10","key":"1762_CR28","doi-asserted-by":"publisher","first-page":"4315","DOI":"10.1002\/cam4.2334","volume":"8","author":"G Hossein","year":"2019","unstructured":"Hossein G, Halvaei S, Dehghani-Ghobadi Z, et al. PectaSol-C modified citrus pectin targets galectin-3 and synergizes with Paclitaxel on ovarian cancer spheroids. Cancer Med. 2019;8(10):4315\u201329. https:\/\/doi.org\/10.1002\/cam4.2334.","journal-title":"Cancer Med"},{"key":"1762_CR29","doi-asserted-by":"publisher","first-page":"73","DOI":"10.4137\/CMO.S285","volume":"1","author":"M Az\u00e9mar","year":"2007","unstructured":"Az\u00e9mar M, Hildenbrand B, Haering B, Heim ME, Unger C. Clinical benefit in patients with advanced solid tumors treated with modified citrus pectin: a prospective pilot study. Clin Med Insights Oncol. 2007;1:73\u201380. https:\/\/doi.org\/10.4137\/CMO.S285.","journal-title":"Clin Med Insights Oncol"},{"issue":"1","key":"1762_CR30","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13048-019-0507-3","volume":"12","author":"H Zare","year":"2019","unstructured":"Zare H, Shafabakhsh R, Reiter RJ, Asemi Z. Melatonin is a potential inhibitor of ovarian cancer: molecular aspects. J Ovarian Res. 2019;12(1):26. https:\/\/doi.org\/10.1186\/s13048-019-0507-3.","journal-title":"J Ovarian Res"},{"key":"1762_CR31","doi-asserted-by":"publisher","first-page":"682","DOI":"10.3389\/fonc.2019.00682","volume":"9","author":"J Smith","year":"2019","unstructured":"Smith J, Fukuda M, Mizuno T, et al. Efficacy of AHCC\u00ae supplementation in women with persistent human papillomavirus infections: a randomized, double-blind, placebo-controlled trial. Front Oncol. 2019;9:682. https:\/\/doi.org\/10.3389\/fonc.2019.00682.","journal-title":"Front Oncol"},{"issue":"3","key":"1762_CR32","first-page":"633","volume":"18","author":"W Suknikhom","year":"2017","unstructured":"Suknikhom W, Lertkhachonsuk R, Manchana T. The effects of active hexose correlated compound (AHCC) on levels of CD4\u2009+\u2009and CD8\u2009+\u2009in patients with epithelial ovarian cancer or peritoneal cancer receiving platinum based chemotherapy. Asian Pac J Cancer Prev. 2017;18(3):633\u20138.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"21","key":"1762_CR33","doi-asserted-by":"publisher","first-page":"7768","DOI":"10.3390\/ijms21217768","volume":"21","author":"M Nunes","year":"2020","unstructured":"Nunes M, Abreu MH, Bartosch C, Ricardo S. Recycling the purpose of old drugs to treat ovarian cancer. Int J Mol Sci. 2020;21(21):7768. https:\/\/doi.org\/10.3390\/ijms21217768.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"1762_CR34","doi-asserted-by":"publisher","first-page":"243","DOI":"10.5582\/ddt.2009.3.6.243","volume":"3","author":"H Hashimoto","year":"2009","unstructured":"Hashimoto H, Messerli SM, Sudo T, Maruta H. Ivermectin inactivates the kinase PAK1 and blocks the PAK1-dependent growth of human ovarian cancer and NF2 tumor cell lines. Drug Discov Ther. 2009;3(6):243\u20136. https:\/\/doi.org\/10.5582\/ddt.2009.3.6.243.","journal-title":"Drug Discov Ther"},{"issue":"1","key":"1762_CR35","doi-asserted-by":"publisher","first-page":"E71","DOI":"10.1073\/pnas.1517188113","volume":"113","author":"M Nishio","year":"2016","unstructured":"Nishio M, Sugimachi K, Goto H, et al. Dysregulated YAP1\/TAZ and TGF-\u03b2 signaling mediate hepatocarcinogenesis in Mob1a\/1b-deficient mice. Proc Natl Acad Sci U S A. 2016;113(1):E71\u201380. https:\/\/doi.org\/10.1073\/pnas.1517188113.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"1762_CR36","doi-asserted-by":"publisher","first-page":"946","DOI":"10.18632\/oncotarget.6350","volume":"7","author":"JE Stine","year":"2016","unstructured":"Stine JE, Guo H, Sheng X, et al. The HMG-CoA reductase inhibitor, simvastatin, exhibits anti-metastatic and anti-tumorigenic effects in ovarian cancer. Oncotarget. 2016;7(8):946\u201360. https:\/\/doi.org\/10.18632\/oncotarget.6350.","journal-title":"Oncotarget"},{"issue":"3 Pt 1","key":"1762_CR37","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1006\/gyno.2000.5908","volume":"78","author":"D Bodurka-Bevers","year":"2000","unstructured":"Bodurka-Bevers D, Basen-Engquist K, Carmack CL, et al. Depression, anxiety, and quality of life in patients with epithelial ovarian cancer. Gynecol Oncol. 2000;78(3 Pt 1):302\u20138. https:\/\/doi.org\/10.1006\/gyno.2000.5908.","journal-title":"Gynecol Oncol"},{"issue":"9","key":"1762_CR38","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1200\/JCO.2005.04.7373","volume":"24","author":"M Markman","year":"2006","unstructured":"Markman M, Liu PY, Rothenberg ML, Monk BJ, Brady M, Alberts DS. Pretreatment CA-125 and risk of relapse in advanced ovarian cancer. J Clin Oncol. 2006;24(9):1454\u20138. https:\/\/doi.org\/10.1200\/JCO.2005.04.7373.","journal-title":"J Clin Oncol"}],"container-title":["Current Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-026-01762-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11912-026-01762-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-026-01762-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T16:09:44Z","timestamp":1771430984000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11912-026-01762-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1762"],"URL":"https:\/\/doi.org\/10.1007\/s11912-026-01762-x","relation":{},"ISSN":["1534-6269"],"issn-type":[{"value":"1534-6269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]},"assertion":[{"value":"22 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"14"}}